Navigating the Spectrum of 4 Evidence-Based Nutrition Options for Type 2 Diabetes Management

被引:0
|
作者
Baskin, Revital Gorodeski [1 ]
Karp, Kimberly A. [2 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Endocrinol, Cleveland, OH 44106 USA
关键词
Mediterranean diet; plant-based diet; low-carbohydrate diet; ketogenic diet; dietary patterns; CARDIOVASCULAR RISK-FACTORS; MEDITERRANEAN DIET; GLYCEMIC CONTROL; KETOGENIC DIET; KETONE-BODIES; ADULTS; MELLITUS; THERAPY; WEIGHT; PREVENTION;
D O I
10.1210/clinem/dgae646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Type 2 diabetes mellitus is a complex, pervasive disease that creates a health and financial burden. The goal is to head off progression to insulin requirement, and dietary changes have been recognized as a first-line intervention in the treatment protocol. Four evidence-based nutritional options are reviewed and their benefits for metabolic consequences.Evidence Acquisition We conducted a comprehensive search of relevant literature using the PubMed database for recent systematic reviews, meta-analyses, and original research articles.Evidence Synthesis The Mediterranean and plant-based diets have demonstrated benefits for the prevention and treatment of diabetes, weight reduction, lipid improvements, and overall cardiovascular risk reduction. A low carbohydrate diet is another viable option for hemoglobin A1c (HbA1c) reduction, though it is not as uniformly defined and is difficult to maintain long term. The ketogenic diet is similarly very restrictive and produces significant HbA1c reductions.Conclusion Type 2 diabetes prevention and treatment is crucial in this widespread disease. The first-line treatment is lifestyle modifications with dietary interventions being at the forefront. With a unique clinical model and a variety of dietary options, our program strives for individualized evidence-based care. Nutritional modifications are the best initial approaches to overcoming insulin resistance and hyperinsulinemia. All dietary modifications, like any medical intervention, require education on benefits vs risks.
引用
收藏
页码:S112 / S117
页数:6
相关论文
共 50 条
  • [41] Emerging treatment options for the management of type 2 diabetes
    Barnett, A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A140 - A141
  • [42] Therapeutic options for the management of type 2 diabetes mellitus
    Takiya, L
    Chawla, S
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (11): : 1009 - 1023
  • [43] A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus
    Billy White
    S. M. Ng
    J. C. Agwu
    T. G. Barrett
    N. Birchmore
    M. Kershaw
    J. Drew
    F. Kavvoura
    J. Law
    C. Moudiotis
    E. Procter
    P. Paul
    F. Regan
    P. Reilly
    P. Sachdev
    R. Sakremath
    C. Semple
    K. Sharples
    M. Skae
    A. Timmis
    E. Williams
    N. Wright
    A. Soni
    BMC Medicine, 22
  • [44] 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
    Marcello Casaccia Bertoluci
    Wellington S. Silva Júnior
    Fernando Valente
    Levimar Rocha Araujo
    Ruy Lyra
    João Jácome de Castro
    João Filipe Raposo
    Paulo Augusto Carvalho Miranda
    Cesar Luiz Boguszewski
    Alexandre Hohl
    Rui Duarte
    João Eduardo Nunes Salles
    José Silva-Nunes
    Jorge Dores
    Miguel Melo
    João Roberto de Sá
    João Sérgio Neves
    Rodrigo Oliveira Moreira
    Marcus Vinícius Bolívar Malachias
    Rodrigo Nunes Lamounier
    Domingos Augusto Malerbi
    Luis Eduardo Calliari
    Luis Miguel Cardoso
    Maria Raquel Carvalho
    Hélder José Ferreira
    Rita Nortadas
    Fábio Rogério Trujilho
    Cristiane Bauermann Leitão
    José Augusto Rodrigues Simões
    Mónica Isabel Natal dos Reis
    Pedro Melo
    Mafalda Marcelino
    Davide Carvalho
    Diabetology & Metabolic Syndrome, 15 (1):
  • [45] Evidence-based European recommendations for the dietary management of diabetes
    Reynolds, Andrew
    Aas, Anne-Marie
    Axelsen, Mette
    Churuangsuk, Chaitong
    Hermansen, Kjeld
    Kendall, Cyril W. C.
    Kahleova, Hana
    Khan, Tauseef
    Lean, Michael E. J.
    Mann, Jim, I
    Pedersen, Eva
    Pfeiffer, Andreas
    Rahelic, Dario
    Reynolds, Andrew N.
    Riserus, Ulf
    Rivellese, Angela Albarosa
    Salas-Salvado, Jordi
    Schwab, Ursula
    Sievenpiper, John L.
    Thanopoulou, Anastasia
    Uusitupa, Matti
    DIABETOLOGIA, 2023, 66 (06) : 965 - 985
  • [46] Intensive Diabetes Management: Negotiating Evidence-based Practice
    Fox, Ann
    CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH, 2010, 71 (02) : 62 - 68
  • [47] 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
    Bertoluci, Marcello Casaccia
    Silva Junior, Wellington S.
    Valente, Fernando
    Araujo, Levimar Rocha
    Lyra, Ruy
    de Castro, Joao Jacome
    Raposo, Joao Filipe
    Miranda, Paulo Augusto Carvalho
    Boguszewski, Cesar Luiz
    Hohl, Alexandre
    Duarte, Rui
    Salles, Joao Eduardo Nunes
    Silva-Nunes, Jose
    Dores, Jorge
    Melo, Miguel
    de Sa, Joao Roberto
    Neves, Joao Sergio
    Moreira, Rodrigo Oliveira
    Malachias, Marcus Vinicius Bolivar
    Lamounier, Rodrigo Nunes
    Malerbi, Domingos Augusto
    Calliari, Luis Eduardo
    Cardoso, Luis Miguel
    Carvalho, Maria Raquel
    Ferreira, Helder Jose
    Nortadas, Rita
    Trujilho, Fabio Rogerio
    Leitao, Cristiane Bauermann
    Simoes, Jose Augusto Rodrigues
    dos Reis, Monica Isabel Natal
    Melo, Pedro
    Marcelino, Mafalda
    Carvalho, Davide
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [48] Evidence-based treatment of type 1 diabetes 2011
    Beck-Nielsen, H.
    10TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS (EACPT), 2011, : 1 - 1
  • [49] Significant gaps persist between management of French people with Type 2 diabetes and evidence-based guidelines.
    Varroud-Vial, M
    Bauduceau, B
    Attali, C
    Attali, JR
    Balarac, N
    Charpentier, G
    Bailleau, C
    Kleinebreil, L
    Preiss, P
    Vaur, L
    Weisselberg, C
    Eschwege, E
    DIABETOLOGIA, 2002, 45 : A308 - A308
  • [50] A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus
    White, Billy
    Ng, S. M.
    Agwu, J. C.
    Barrett, T. G.
    Birchmore, N.
    Kershaw, M.
    Drew, J.
    Kavvoura, F.
    Law, J.
    Moudiotis, C.
    Procter, E.
    Paul, P.
    Regan, F.
    Reilly, P.
    Sachdev, P.
    Sakremath, R.
    Semple, C.
    Sharples, K.
    Skae, M.
    Timmis, A.
    Williams, E.
    Wright, N.
    Soni, A.
    BMC MEDICINE, 2024, 22 (01)